June 2, 2010 ·
Leave a comment
Paul Meade, a 25-year veteran of the pharmaceutical industry, founded Thought Leader Select in 2006. Throughout his career, Paul served in several leadership positions in sales, marketing, and strategic planning, culminating in his role of director of worldwide commercial development for predictive medicine at GlaxoSmithKline.
After leaving GSK, Paul launched two companies, Clear Point Health, in 2005, and Thought Leader Select, in 2006. Paul’s work with these two companies entails marketing planning, consulting for research and development and clinical operations, as well as his breakthrough work with medical expert collaborations for the pharmaceutical industry.
The Thought Leader Select Blog sat down with Paul to discuss his industry experience and his professional contribution to Thought Leader Select.
TLS Blog: Good afternoon, Paul. Why did you start Thought Leader Select?
Paul Meade: About a year before starting the company, I had begun consulting with the health industry with my partner, Lisa Smith, through our company, Clear Point Health. We were taking on a number of projects, working with medical affairs teams, marketing teams, and research and development groups within the industry.
One of our large clients came to me and told me that, even though they’d been working with thought leaders for over ten years, they realized how little they really knew about them. When they sat down to consolidate all of their knowledge about their medical ... read more »
TAGS:
advisory boards
biotechnology
Civil Air Patrol
Clear Point Health
clinical operations
clinical research
clinical trials
commercial development
committees
Gillings School for Global Public Health
GlaxoSmithKline
Johns Hopkins University
key opinion leaders
KOL engagement
KOL identification
KOL profiling
KOLs
marketing planning
master of public health
medical ethics
medical experts
Merck
Paul Meade
pharmaceutical
pharmaceutical marketing
pharmaceutical sales
predictive medicine
public health
publishing
research and development
research methodology
The Immortal Life of Henrietta Lacks
Thought Leader Select
thought leaders
transparency
United States Air Force
University of North Carolina at Chapel Hill
May 11, 2010 ·
Leave a comment
May 11, 2010 (CHAPEL HILL, NC) Paul Meade, founder and president of Thought Leader Select, a North Carolina firm dedicated to key opinion leader (KOL) development solutions for the biopharmaceutical industry, received a master of public health degree from the University of North Carolina at Chapel Hill on May 8, 2010.
The Gillings School of Global Public Health at UNC awarded Meade, a 25-year veteran of the pharmaceutical industry, with a master of public health degree and a certificate in public health ethics in the Public Health Leadership Program. Meade’s research report, “How Volunteer Community Organizations Can Assist State Public Health Departments During Pandemic Influenza,” explored specific possibilities for the Civil Air Patrol, a volunteer non-profit national organization and an auxiliary of the United States Air Force, to assist state public health officials during widespread outbreaks of influenza.
The master of public health degree is Meade’s second master’s degree. He earned a master of science in biomedical science from the University of Guelph (Canada) in 1977, following his bachelor of science degree in biology and chemistry from Acadia University (Canada) in 1971.
During his 25-year career in the pharmaceutical industry, Meade served in a variety of leadership positions at Merck and GlaxoSmithKline. During his ten years at Merck, Meade worked his way from a sales representative position to director of marketing planning for ... read more »
TAGS:
biopharmaceutical
biotechnology
certificate
Civil Air Patrol
Clear Point Health
clinical operations
clinical researchers
Gillings School of Global Public Health
GlaxoSmithKline
healthcare ethics
healthcare policy
healthcare research
key opinion leaders
KOL deployment
KOL development
KOL engagement
KOL identification
KOL profiling
KOLs
marketing planning
master of public health
medical affairs
Merck
nurses
Paul Meade
pharmaceutical
pharmacists
physician assistants
physicians
predictive medicine
public health ethics
Public Health Leadership Program
research and development
Thought Leader Select
United States Air Force
University of North Carolina at Chapel Hill
veterinarians
April 22, 2010 ·
Leave a comment
April 22, 2010 (CHAPEL HILL, NC)—Thought Leader Select, a North Carolina company dedicated to better engagement and more sophisticated deployment of key opinion leaders (KOLs) for the pharmaceutical and biotechnology industries, announces the hiring of Lynda Scott as research manager.
Ms. Scott, a native of Johannesburg, South Africa, has served as a research associate at the firm for the last three years. In addition to her work at Thought Leader Select, Scott brings nearly a decade of valuable clinical experience to the firm, spending seven years as a nuclear medicine radiographer at the Flora Clinic and Milpark Hospital, as well as the Rosebank Clinic, all in Johannesburg. At the Rosebank Clinic, Scott managed all aspects of the nuclear medicine practice, including patient management, general practice management, record-keeping, and adherence to industry protocols and regulations.
Scott earned a Master of Health Science degree from the University of Sydney, Austrailia, in 2004, graduating with highest honors. During her time as a student at the University of Sydney, Scott twice presented her work in imaging at Duke University Medical Center, and in 2004, the Journal of Nuclear Medicine Technology published her work covering the role of MIBG imaging in early diagnosis of cardiac autonomic neuropathy in diabetes patients.
Since completing her master’s degree, Scott has worked as an independent medical writer, contributing to two HIV-related manuscripts ... read more »
TAGS:
biotechnology
Flora Clinic
GlaxoSmithKline
key opinion leaders
KOL identification
KOL management
KOL profiling
Lynda Scott
Milpark Hospital
nuclear medicine
pharmaceutical
research
Rosebank Clinic
Thought Leader Select
University of Sydney